NSGC Genomic Technologies and Health IT SIG Webinar Series:
AI 101

November 3rd, 2020

In this webinar titled Artificial Intelligence (AI) 101 hosted by the National Society of Genetic Counselors welcomed guest speaker Dr.
Mark Kiel, co-founder and Chief Science Officer at Genomenon.

Attendees learned about the fundamentals of Artificial Intelligence and its implication in medical genomics—now and in the future.

Learning Objectives:

  • The distinction between narrow and general artificial intelligence, including a description of the
    various subtypes of narrow AI from a non-technical perspective
  • Examples of current and emerging technologies and their relevance to the genomic/precision
    medicine space
  • An overview of the challenges to the adoption of AI in genomics

Learn more about the National Society of Genetic Counselors.


Dr. Mark Kiel, Chief Science Officer – Genomenon

Mark Kiel completed his MD Ph.D. and Molecular Genetic Pathology Fellowship at the University of Michigan, where his research focused on stem cell biology, genomic profiling of hematopoietic malignancies, and clinical bioinformatics. He is the founder and CSO of Genomenon, where he supervises the scientific direction of the Mastermind suite of software tools.